The Rivkin Center is proud to announce that the organization has awarded $345,000 in ovarian cancer research grants to four scientists from the United States and abroad. Although 2020 proved to be a challenging year for small nonprofits, the Rivkin Center is thankful that we are still able to fund critical, life-saving research, thanks to our community. To date, the Rivkin Center has funded $14.3 million in ovarian cancer research grants.
Despite being the deadliest gynecological cancer, ovarian cancer continues to be underfunded by federal funding agencies when compared to other cancers. Our unique approach to seed funding provides ovarian cancer researchers leverage to access larger pots of federal funds to make a major impact in moving science forward. For every dollar the Rivkin Center invests in research, Rivkin Awardees bring in an additional $14.20 in outside funding to further their life-saving work in ovarian cancer.
Our 2021 Awardees will lead high-impact research projects focused on improving early detection methods, developing novel therapies to treat the disease, and understanding resistance to chemotherapy. The funded studies include three Pilot Study Awards, which provide funding for novel ideas and innovative approaches to research questions that venture out of the scientific mainstream. We also funded one Scientific Scholar Award, which is designed to attract new investigators to ovarian cancer research and support the novel ideas they bring to the table.
The mission of the Rivkin Center is to improve women’s health by helping them prevent, detect early, and survive ovarian and breast cancer. We do this by investing in cutting-edge ovarian cancer research, educating women on how to prevent and detect ovarian and breast cancer as early as possible, and fostering an ever-growing community of survivors, patients, researchers, clinicians, advocates, and supporters.
Help fund more ovarian cancer research by making a donation to the Rivkin Center today: